ASX:GMV

G Medical Innovations Holdings Ltd (GMV.AX) (GMV) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
396,612 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About G Medical Innovations Holdings Ltd (GMV.AX)

G Medical Innovations Holdings Ltd operates as a mobile health and e-health company. It develops and markets clinical and consumer medical-grade health monitoring solutions. The company develops Medical Smartphone Case, a solution that turns a phone into a mobile medical monitoring device; and G Medical Patch, a solution that provides continuous and real-time monitoring of a range of vital signs and biometrics. G Medical Innovations Holdings Ltd was founded in 2014 and is based in George Town, Cayman Islands.

GMV Stock News Headlines

Momentum Metropolitan Holdings Ltd MTM
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
Trajan Group Holdings Limited (TRJ.AX)
GMVD G Medical Innovations Holdings Ltd
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
G Medical Innovations Holdings Ltd (GMVDW)
Vincent Medical Holdings Ltd (1612)
China Resources Medical Holdings Company Ltd
See More Headlines
Receive GMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for G Medical Innovations Holdings Ltd (GMV.AX) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.63 million
Book Value
A($0.01) per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Yacov Geva (Age 69)
    Pres, CEO & Exec. Director
  • Mr. Rafi Heumann (Age 49)
    Pres & COO
  • Mr. Kobi Ben-Efraim (Age 62)
    Chief Financial Officer
  • Mr. Nir Geva (Age 45)
    Chief Technology Officer
  • Mr. Oded Shahar (Age 58)
    Sr. Investment Banker and Sr. VP of Merger & Acquisition

This page (ASX:GMV) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners